As of Jul 31
| +0.18 / +2.84%|
The 2 analysts offering 12-month price forecasts for Fibrocell Science Inc have a median target of 8.13, with a high estimate of 9.25 and a low estimate of 7.00. The median estimate represents a +24.62% increase from the last price of 6.52.
The current consensus among 2 polled investment analysts is to Buy stock in Fibrocell Science Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.